Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RANI
#3426
Rani Therapeutics Holdings, Inc. Class A Common Stock
1.3
7
-0.72%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.72%
Monthly Change
-0.72%
6 month change
+140.35%
Year Change
-8.67%
Previous Close
1.3
8
Open
1.3
7
Bid
Ask
Low
1.3
7
High
1.3
7
Volume
19
Markets
US Stock Market
Healthcare
RANI
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2021
2022
2023
2024
TTM
Cash from operating activities
32.2 M
46.5 M
51.2 M
35.5 M
27.66 M
Cash from investing activities
506 K
72.44 M
29.86 M
19.81 M
26.46 M
Cash from financing activities
77.15 M
29 M
233 K
13.59 M
10.17 M
Free cash flow
31.69 M
44.88 M
49.97 M
35.23 M
27.54 M
News
Rani Therapeutics promotes Alireza Javadi to chief technical officer
Rani Therapeutics begins phase 1 trial of oral obesity treatment
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement
Rani Therapeutics announces $1.085 billion Chugai collaboration
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%
Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27
Rani Therapeutics director Imran Mir a buys $1.26 million in stock
Rani Therapeutics appoints new directors and closes private placement
Rani Therapeutics adds two biotech investors to board of directors
Rani Therapeutics closes $60.3 million private placement
South Cone investments sells Rani Therapeutics (RANI) shares for $15.7m
3 Penny Stocks to Watch Now, 10/22/25 - TipRanks.com